ValerieMalyvanhJansenMD

PubMed

• 37 citations
  Changes in peripheral and local tumor immunity after neoadjuvant chemotherapy reshape clinical outcomes in patients with breast cancer
  Margaret L Axelrod, Mellissa J. Nixon, Paula I. Gonzalez-Ericsson, Riley E. Bergman, Mark A. Pilkinton
  Clinical Cancer Research. 2020-08-21
• 241 citations
  Aberrant FGFR signaling mediates resistance to CDK4/6 inhibitors in ER+ breast cancer
  Luigi Formisano, Yao Lu, Alberto Servetto, Ariella B. Hanker, Valerie M. Jansen
  Nature Communications. 2019-03-26
• 23 citations
  Association of FGFR1 with ERα Maintains Ligand-Independent ER Transcription and Mediates Resistance to Estrogen Deprivation in ERBreast Cancer.
  Luigi Formisano, Kimberly M Stauffer, Christian D Young, Neil E Bhola, Angel L Guerrero-Zotano
  Clinical Cancer Research. 2017-10-15

Journal Articles

• Palladium-bacterial Cellulose Membranes for Fuel Cells  
  Evans BR, O'Neill HM, Malyvanh VP, Lee I, Woodward J, Biosens Bioelectron, 1/1/2003

Abstracts/Posters

• TORC inhibition enriches for a cancer stem cell-like population with FGFR-dependent Notch1 activation.
  Bhola NE, Jansen VM, Arteaga CL, Annual Meeting of the American Association for Cancer Research, Philadelphia, PA, 1/1/2015
• RNA interference kinome-wide screen reveals a role for PDK1 in acquired resistance to CDK4/6 inhibition in ER-positive breast cancer.
  Jansen VM, Bhola NE, Bauer JA, Arteaga CL, (Minisymposium) Annual Meeting of the American Association for Cancer Research, Philadelphia, PA, 1/1/2015
• Nuclear FGFR1 interaction with estrogen receptor (ER) alpha is associated with resistance to endocrine therapy in ER+/FGFR1-amplified breast cancer.
  Formisano L, Young CD, Bhola NE, Bulen B, Estrada VM, Wagle N, Van Allen E, Red Brewer ML, Jansen VM, Guerrero AL, Giltnane JM, Strcker T, Arteaga CL, San Antonio Breast Cancer Symposium, San Antonio, TX, 1/1/2015
• Inhibition of 3-phosphoinositide dependent protein kinase 1 (PDK1) synergizes with CDK4/6 inhibitors against ER-positive breast cancer.
  Jansen VM, Bhola NE, Bauer JA, Formisano L, Moore P, Koch J, Arteaga CL, San Antonio Breast Cancer Symposium, San Antonio, TX, 1/1/2015
• TORC inhibitors increase the cancer stem cell (CSC) population and Notch signaling in triple negative breast cancer.
  Bhola N, Jansen V, Arteaga C, Annual Meeting of the American Association for Cancer Research, San Diego, CA, 1/1/2014
• Targeting Polo-like kinase I (PLK1) can overcome estrogen-independent growth in ER+ human breast cancer.
  Jansen VM, Bhola N, et al, ASCI/AAP Joint Meeting, Chicago, IL, 1/1/2014
• Inhibition of polo-like kinase 1 (PLK1) in endocrine resistant ER+ breast cancer. (Poster Highlights Session) Annual Meeting of the American Society of Clinical Oncolo...
  Jansen VM, Bhola N, et al, Annual Meeting of the American Society of Clinical Oncology, Chicago, IL, 1/1/2014
• Altered Erythroid and Megakaryocytic Differentiation in Mice Expressing a Unique Chromatin Remodeling Domain of Erythroid Kruppel-Like Factor (EKLF).
  Jansen VM, Abramova T, Shim E-H, Ramachandrann S, Desgardin A, Parekh V., Jane SM, and Cunningham JM, Blood (ASH Annual Meeting Abstracts), Annual Meeting of the American Society of Hematology, San Francisco, CA, 1/1/2008
• Context-Specific Roles for Erythroid Kruppel-Like Factor (EKLF) in Co-Ordinate High Level Expression of the Murine alpha-and Beta-Globin Genes.
  Jansen, VM, Ramachandran S, Desgardin A, He J, Parekh V, Jane SM, and Cunningham JM, Blood (ASH Annual Meeting Abstracts), Annual Meeting of the American Society of Hematology, Orlando, FL, 1/1/2006
• Reduction and Release of Ferritin Iron in the Presence of Vitamins.
  Malyvanh VP, 15th National Conference on Undergraduate Research, Lexington, KY, 1/1/2001
• Reduction and Release of Ferritin Iron in the Presence of Vitamins.
  Malyvanh VP, Council on Undergraduate Research Poster on the Hill, Washington, DC, 1/1/2001
• Synergy and Processivity in Hydrolysis of Cellulose by Cellobiohydrolases I and II.
  Malyvanh VP, Evans BR, Woodward J, Annual Meeting of the American Chemical Society, San Diego, CA, 1/1/2001
• Join now to see all

Lectures

• "RNA interference kinome-wide screen reveals a role for PDK1 in acquired resistance to CDK4/6 inhibition in ER-positive breast cancer." 
  Vanderbilt University Medical Center - 1/21/2016
• "Identifying Novel Rational Combination Therapies for Breast Cancer." 
  Vanderbilt University Medical Center - 1/14/2015
• "ESR1 (estrogen receptor) mutations in ER+ breast cancer: are they ‘actionable'." 
  Vanderbilt University Medical Center - 1/12/2015
• "Gynecologic Cancers." 
  Vanderbilt University Medical Center - 1/6/2014
• "Anal Cancer." 
  Vanderbilt University Medical Center - 1/24/2013
• "Oncologic Emergencies." 
  Vanderbilt University Medical Center - 1/23/2013
• Fellows Division Conference 
  Vanderbilt University Medical Center - 1/8/2013
• "Can you have it ALL?" 
  Vanderbilt University Medical Center - 1/30/2012
• "Supportive Oncology Case Conference." 
  Vanderbilt University Medical Center - 1/29/2012
• "Thrombosis and Thrombophilia." 
  Vanderbilt University Medical Center - 1/26/2012
• "Ovarian Cancer." 
  Vanderbilt University Medical Center - 1/24/2012
• "Peripheral Blood Smears: The Basics." 
  Vanderbilt University Medical Center - 1/15/2012
• "Blastic Plasmacytoid Dendritic Cell Neoplasm." 
  Vanderbilt University Medical Center - 1/14/2012
• "Trousseau's Syndrome: Cancer, Thrombosis, and Anticoagulation." 
  Vanderbilt University Medical Center - 1/30/2011
• Join now to see all

Other

• "Early stage breast cancer: How to know whether to forgo chemo." 
  Jansen VM, Mayer IA, The Conversation
  https://theconversation.com/early-stage-breast-cancer-how-to-know-whether-to-forgo-chemo-64645
  1/1/2016
• Generation and characterization of a knock-in allele of EKLF: Probing the in vivo role of the chromatin remodeling domain in definitive hematopoietic cells. 
  Jansen VM, The University of Tennessee Health Science Center
  Memphis, TN - 1/1/2009
• Reduction and Release of Ferritin Iron in the Presence of Vitamins 
  Malyvanh VP, Senior Thesis, Maryville College
  Maryville, TN - 1/1/2001
• Generation and Characterization of a Knock-In Allele of EKLF: Probing the In Vivo Role of the Chromatin Remodeling Domain in Definitive Hematopoietic Cells 
  Malyvanh VP, Dissertation, University of Tennessee Health Science Center College of Medicine and St Jude Children
  Memphis, TN
• Join now to see all